Skip to content

Clinical trials

Lymphoma, Large-Cell, Anaplastic trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large-Cell, Anaplastic Phase: Not applicable Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20043
20062
20075
20082
20092
20101
20111
20131
20151
20161
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Withdrawn7
Terminated5
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center4
Case Comprehensive Cancer Center3
Wake Forest University Health Sciences3
City of Hope Medical Center2
Eastern Cooperative Oncology Group2
M.D. Anderson Cancer Center2
Mayo Clinic2
Roswell Park Cancer Institute2
Asan Medical Center1
Astex Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large-Cell, Anaplastic29
Lymphoma, Large B-Cell, Diffuse25
Burkitt Lymphoma23
Lymphoma, Follicular23
Immunoblastic Lymphadenopathy22
Leukemia, Lymphocytic, Chronic, B-Cell22
Lymphoma, Mantle-Cell22
Precursor Cell Lymphoblastic Leukemia-Lymphoma21
Lymphoma, B-Cell, Marginal Zone20
Lymphoma, Non-Hodgkin20

Trials

Showing 76 to 29 of 29. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.